ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_2989 # 3057576 # 3057665 # -1 # ID=1_2989;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.567	scaffold_1_2989 	3057576	3057665	-	Strict	600	18.8606	clbB	100.0	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGGGAGAGGGTTATGAAATGGTATTTGGCGGGGAAGAAGGGGAGGTAGGCTGTGGGTGTGGCTTTTGGGGGAAGGTCGGCTTGCCTTGA	MGEGYEMVFGGEEGEVGCGCGFWGKVGLP	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	8.45	gnl|BL_ORD_ID|112|hsp_num:0	127	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_3535 # 3553390 # 3553506 # -1 # ID=1_3535;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.470	scaffold_1_3535 	3553390	3553506	-	Strict	700	20.4014	vanWI	100.0	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGCCGAACCTGTTGTCTCAGAAGATGTCTCGGGGTGCGGAAGAGGGTTCTCTTGGTGTTAGATACCTATCTGACTCTGTGCTAGTTCGTGATAGTTGTAAACCCAAGCTACAGTAG	MPNLLSQKMSRGAEEGSLGVRYLSDSVLVRDSCKPKLQ	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	10.19	gnl|BL_ORD_ID|2083|hsp_num:0	2242	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_629 # 647111 # 647308 # -1 # ID=2_629;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.465	scaffold_2_629 	647111	647308	-	Strict	900	21.9422	otr(B)	100.0	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGAGGTTCGTGTTCGATTCACGGCAGTTGCATATTTTTTTTTTTGTTTTTTTTTTTTTGAAAACTTTTTTTTTGGGTGGTGGGGGTGGGGCTCGCCACGCAAAAAAAGGGGGTATGCGAGAATAGATAGGTACGCACACGGGGGAAGGAGGAGGGGGGGGGGAGGGGGGGGGGTATTATATATTTGTTTTTTCTAG	MEVRVRFTAVAYFFFCFFFFENFFFGWWGWGSPRKKRGYARIDRYAHGGRRRGGGGGGVLYICFF	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	11.55	gnl|BL_ORD_ID|910|hsp_num:0	870	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1101 # 1061811 # 1061975 # -1 # ID=2_1101;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.521	scaffold_2_1101 	1061811	1061975	-	Strict	1900	20.4014	TriC	100.0	3003681	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGAGGACGTTGCTTCGCAGCTGGGAACTTTTTCGAGGTATTCTGGGGGCCGAGACGTGCCAATGACGAAATTGGTATCAGAATCTACCTACCTAAGGTACAGTATCGTCGAACGGGTCCCGGGGCTGTTACAAATTTCACCAGGGCGGAAGTTGGGCCATAA	MRGRCFAAGNFFEVFWGPRRANDEIGIRIYLPKVQYRRTGPGAVTNFTRAEVGP	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	5.32	gnl|BL_ORD_ID|2049|hsp_num:0	2194	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1868 # 1862668 # 1862871 # -1 # ID=2_1868;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.632	scaffold_2_1868 	1862668	1862871	-	Strict	300	21.1718	AAC(2')-IIa	100.0	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGGCCCTCATGCGGGTCGATCTTGGAGACGCGCAGCGCGAGCAGAGACATGGGCAGCAGCTTGAAGGTGTTTTCGAGGGAGGCGCGGTCGGTGATCTCGGGGAGGAGGGGGTTCTTCTTGCGGGCTTTCTCGTAGGCTGGGGATTGCAGGGCGCGGAGGGCGCGCTTGACTGGGTGGTGTTTTGGTTAGCTGGGTGTTCTTGA	MALMRVDLGDAQREQRHGQQLEGVFEGGAVGDLGEEGVLLAGFLVGWGLQGAEGALDWVVFWLAGCS	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	25.77	gnl|BL_ORD_ID|2266|hsp_num:0	3327	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1932 # 1930551 # 1930877 # -1 # ID=2_1932;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.462	scaffold_2_1932 	1930551	1930877	-	Strict	700	23.0978	gimA	100.0	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	GTGTTGGAAATCGAGCAGCTTTCAAACCTTGATGCTTGGCTCAGGTCCGTTCTTTGGAACTCCACGCTTCCCGGCCTTGGTTCCAATTCAGAAGACCACAACAAGCTTGAGATCCATAGATTGAAAGCCAGGTTACCATTCTCAAATGGGGAAGTAAAGATTGTTCAAGGTGTTCGGGAGGTATTTGAGATCTTGGACGCTCCGACAATCGATGGTTCTATATCTGCGGCCGCTGTCCCTTCAACAGGGAAGATAGTGTTGATTGGGAGAGAACTTCAAGGCCTGAGGTTTGAGGAAAGCTTTAGAAATACAATAAAATCCGGATGA	MLEIEQLSNLDAWLRSVLWNSTLPGLGSNSEDHNKLEIHRLKARLPFSNGEVKIVQGVREVFEILDAPTIDGSISAAAVPSTGKIVLIGRELQGLRFEESFRNTIKSG	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	25.90	gnl|BL_ORD_ID|1973|hsp_num:0	1994	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_2292 # 2408733 # 2408888 # -1 # ID=2_2292;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.468	scaffold_2_2292 	2408733	2408888	-	Strict	250	20.4014	arr-7	100.0	3002852	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	GTGGCAGTGATTATCTGTACAGTGAGTGTGTTTTTACGTGGGCTCTATTCTACCTTACCTATCGGGAATCGTCATCGTGGCTATATATACATTGTTGAAGACAAGTATGTCATTCCCTGTGCCCCGTGCGGCGCCTTTGGTTATGGCACCGACTGA	MAVIICTVSVFLRGLYSTLPIGNRHRGYIYIVEDKYVIPCAPCGAFGYGTD	MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPAIWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVEDWQGHSPDVLQGMLASLEDLQRRGLAIIED	34.00	gnl|BL_ORD_ID|694|hsp_num:0	736	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_209 # 246845 # 247012 # -1 # ID=3_209;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.542	scaffold_3_209 	246845	247012	-	Strict	350	20.4014	bcrC	100.0	3003250	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	undecaprenyl pyrophosphate related proteins	ATGCCTGGGTTGAGATGGTGCTATCTAATTCTGAATTATGAGTTGGGTTGGGTTGGGTTGGTGGTGGGTGGGTTGTTGTGGGCCTGTGGTGGGGGGGAGGGGGAGGGAGAAGAGGTGGTTGGTTGGTTGTGGTTGGTTAGAAGAGAGGGAGAGCGGGTTGGACGTTAA	MPGLRWCYLILNYELGWVGLVVGGLLWACGGGEGEGEEVVGWLWLVRREGERVGR	MSFSELNIDAFRFINDLGKEYSMLNPVVYFLAEYMMYFLALGLVVYWLTRTTKNRLMVIYAVIAFVVAEILGKIMGSLHSNYQPFATLPNVNKLIEHEIDNSFPSDHTILFFSIGFLIFLFHKKTGWLWLVLAFAVGISRIWSGVHYPLDVAAGALLGVLSALFVFWTAPKLSFIHQMLSLYEKVEQRIVPSKNKSNDKSKNF	27.09	gnl|BL_ORD_ID|199|hsp_num:0	215	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_528 # 659295 # 659420 # 1 # ID=3_528;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.524	scaffold_3_528 	659295	659420	+	Strict	1050	19.631	vgaA	100.0	3002829	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGTTATTACCAAGGAGGCGGTTGAGATGGGGTGGCTGGTTGGAGAGAGCCTCGGAGCCTCAGAGGGGAGGATTACAGAGTACGCAGTAATGACTGATTGCGTCTACAATACTTCTTGGGCTTGA	MVITKEAVEMGWLVGESLGASEGRITEYAVMTDCVYNTSWA	MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK	7.85	gnl|BL_ORD_ID|541|hsp_num:0	579	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_439 # 447931 # 448056 # 1 # ID=4_439;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.508	scaffold_4_439 	447931	448056	+	Strict	500	20.0162	chrB	100.0	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAGCGCACTACATGAGGATATTGACGGATGGCACGAATTTCTTTTTTTCGCCTCGGAAGAATGTCAAGCTTGGCACCGAGATGCAATGGACTGGATGACTGGGCGTTCCTCGGAGGAGCCTTGA	MSALHEDIDGWHEFLFFASEECQAWHRDAMDWMTGRSSEEP	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	14.64	gnl|BL_ORD_ID|284|hsp_num:0	305	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_95 # 215355 # 215495 # 1 # ID=5_95;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.518	scaffold_5_95 	215355	215495	+	Strict	350	20.4014	catB3	100.0	3002676	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGATGGTGGACTGATTATGTTAAGTGGAGTGGAGAGTTTTGGGGGGGGTGAGTGGTGGAACTGGAAGAAGTTAGAACTGAGAGAGGTGAATGGATGGATTCACTGGGCGGGCCAAGACAGGTCGACTCGTGAGTGGTGA	MDGGLIMLSGVESFGGGEWWNWKKLELREVNGWIHWAGQDRSTREW	MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPMLCSSNIVGLHKYWLEFAV	21.90	gnl|BL_ORD_ID|134|hsp_num:0	150	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_1187 # 1244025 # 1244126 # -1 # ID=9_1187;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.451	scaffold_9_1187 	1244025	1244126	-	Strict	1000	19.631	Clostridium perfringens mprF	100.0	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGTGGGCAAATGAGGGAGAAAGGGGGAAGGAAAAGGAGAAGGGGGAGGGAGAGGTAGAGATATGGATGTCTGAATGTTTAGGATATGGTACTAAAAACTAA	MWANEGERGKEKEKGEGEVEIWMSECLGYGTKN	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	5.80	gnl|BL_ORD_ID|2110|hsp_num:0	2282	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_218 # 223442 # 223630 # 1 # ID=10_218;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.545	scaffold_10_218 	223442	223630	+	Strict	2000	21.1718	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	100.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAGCTCAGTGTGGCTTATTGGGAATGAACGGAGCGAGTTGGTTTTGAATGATGGATGGGCGAATTACACGGGGGGCGGGGTCAGCCTTACCTGTCGTTACAAGCGGTATATGAAGGGGGTTGGGACACTAGCGCGGGAGAACGAGACATACCTACCTACCTCACCTACGGTCCAGACCCTTCGATAG	MSSVWLIGNERSELVLNDGWANYTGGGVSLTCRYKRYMKGVGTLARENETYLPTSPTVQTLR	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	5.23	gnl|BL_ORD_ID|2668|hsp_num:0	2914	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_33 # 44137 # 44676 # -1 # ID=11_33;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.593	scaffold_11_33 	44137	44676	-	Strict	700	23.8682	ACT-14	100.0	3001836	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCGGCCCCGTCTCATCTACCCCCGCGACGAGGAGCCCGACACCATAAGGTCGCTTCCCATAGTGTTGGGTGTTGGTCTGCGCGCGGTCGCCGATGGCCGATACCAGGCGCTCGAGGGGAATGGCGCGGCCGTAGGTGAGGCGGGAGGACAGCGACTGCTGCTTCATGAAGTTGGAGAGGACGCGGGCGTCGGATGCGAGACCGGCCAGCGAGAGGCCCAGGTGCTCATCGATGGCGATTATCTTCTTCTGATACGAGGAGAGCTCTTCTGCGTTGCGCTGGACAGCGTGGGCTCGTCAGCTTGGGGCCCCGGCGTGTTGTTGGTTGGGGGGTTTGGATCATATCTTGCCTTTAACGCAACGAGAACAGCATGTGTCTTGCTCACTATCCCCACCACCACTGAACCCTGCTTTACGGCTTCAGACGCATACTCGACTTGGAAAATCCGTCCTTGGGGAGAGCTATGCGTAAGTCAGCTTGAGCGCGTCGGTATGCAGCTTCGAACCACCACTCACAAGGTAACCGAGTCGTTATCGTAG	MRPRLIYPRDEEPDTIRSLPIVLGVGLRAVADGRYQALEGNGAAVGEAGGQRLLLHEVGEDAGVGCETGQREAQVLIDGDYLLLIRGELFCVALDSVGSSAWGPGVLLVGGFGSYLAFNATRTACVLLTIPTTTEPCFTASDAYSTWKIRPWGELCVSQLERVGMQLRTTTHKVTESLS	MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYLAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	46.98	gnl|BL_ORD_ID|1450|hsp_num:0	1541	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_1157 # 1180145 # 1180471 # 1 # ID=11_1157;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.450	scaffold_11_1157 	1180145	1180471	+	Strict	990	22.7126	farB	100.0	3003962	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCTACTTTCGTGGATAAGACGCCCTTTGTTTTTGTCATCTTTTGGGGGTGGATATTTTTCATACCCGGGGTTGTAATTGAGTATGGGGGAGACCCACTAGGCCTATGTGGAGGGACTGGGGGACTGGGAATCTCAATACAAACCCCTGCACCATGTAGCCTGCTGGTTGGGGACCTTTGTTTTTATCTTTTTGCTCTAAGCTATACTGCTGCAGTTTGTCTACCTAGGTTCCTTCTATCTTTTTACTTTTACTTTTACTTTTGCTTTTCTTTCCTGTCGTTCTTTCCGTGCGGTTGTGGAAGGGATGATGATGATGATGGCTGA	MSTFVDKTPFVFVIFWGWIFFIPGVVIEYGGDPLGLCGGTGGLGISIQTPAPCSLLVGDLCFYLFALSYTAAVCLPRFLLSFYFYFYFCFSFLSFFPCGCGRDDDDDG	MDYPPLKGAALAWVTLSLGLAVFMEVLDTTIANVAVPVIAGNLGAATTQGTWVITSFSVANAVSVPLTGFLAKRIGEVKLFTAAAVGFVITSWLCGIAPNLQSLVVFRILQGFIAGPLIPLSQSLLMASYPPAKRTLALALWAMTVVVAPVLGPILGGWISGNWHWGWIFFINIPIGIISAWITWKHLKYRETETVKMPTDYVGLTLMVVGIGALQMMLDRGKELDWFASGEIITLGVVALVCLSYFIVWELGEKYPIVDLSLFKDRNFTVGVIATSLGFMVYMGTLTLLPLVLQTNLGYTSTWAGLAAAPVGILPVFLSPLIGRFGNKIDMRLFVTASFLTFAFTFYWRTDFYADMDIGNVIWPQFWQGVGVAMFFLPLTTITLSHMKGGQIAAAGSLSNFLRVLMGGVGVSVVSTLWERREALHHTRFAEHITPYSATLHETAAHLSQHGVSDIQTLGIINNTITQQGFIIGSNEIFMAGSLLFIIMIPVIWLAKPPFHNGGGGGH	21.26	gnl|BL_ORD_ID|2246|hsp_num:0	2429	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_951 # 969835 # 970035 # -1 # ID=13_951;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	scaffold_13_951 	969835	970035	-	Strict	2300	21.1718	evgS	100.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTGGGATACTTTCAAGGATGTGTTTTCCAACGCCATACAGTTCGGTCAGGCAACCATGAAGGACGATGATTGTCTATTCCTCAAAAGGAACGGATTACTAGAAGAGACTTATTTCACTTGGGCAATAGCTCCTCTTGTGGGTGCAGATGGATCAGGTTCGTACTCCCTGAGTAAATTGCTTTGTCTTCGTACTTCATGA	MWDTFKDVFSNAIQFGQATMKDDDCLFLKRNGLLEETYFTWAIAPLVGADGSGSYSLSKLLCLRTS	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	5.51	gnl|BL_ORD_ID|1243|hsp_num:0	1318	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_535 # 532298 # 532453 # -1 # ID=14_535;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.538	scaffold_14_535 	532298	532453	-	Strict	500	21.9422	Rhodococcus fascians cmr	100.0	3002701	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGACGCTAGTACACACGCTATACCGCGGGCCAGGTATCGAGACGACTACGTTTGAGCCGCGCCATGCTAAGGGGCTCAGTAATGAGTTTTTCTGCTATGCGAATTTTGAGAGTGAGTTGTGGGGATGGAGAAGGAAGGATGGGGCGGAGTGA	METLVHTLYRGPGIETTTFEPRHAKGLSNEFFCYANFESELWGWRRKDGAE	MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAIVSMRWQRRRALLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMVPADMKGRATSVLLGGVTIACVVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPADSPTDSVPNATRELSSLRQRKLQLILVLGALINGATFCSFTYLAPTLTDVAGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLVAGSAALLVGWIVFAITASHPVVTLVMLFVQGTLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALGPALGGVAIGIGMGYRAPLWTSAALVALAIVIGAATWTRWREPRPALDTVPP	13.04	gnl|BL_ORD_ID|305|hsp_num:0	250	True	loose hit with at least 95 percent identity pushed strict
